Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone vs Olive Oil Cream for Prevention of Acute Radiodermatitis in Breast Cancer
NCT05285943Phase 4Completed
- Sponsor
- Cairo University
- Start
- Nov 2021
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of betamethasone valerate 0.1% cream, olive oil in acute radiodermatitis (ARD), sponsored by Cairo University. Started Nov 2021; status: completed.
02
Drugs
betamethasone valerate 0.1% creamolive oil
03
Conditions
acute radiodermatitis (ARD)
Beyond the preview
Go deeper on NCT05285943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05285943.